The Complexity of the PARP Inhibitor Landscape in Ovarian Cancer

June 16, 2017
Douglas A. Levine, MD

Douglas A. Levine, MD, professor, Department of Obstetrics and Gynecology, and director, Divison of Gynecologic Oncology, NYU Langone Medical Center, discusses the impact of PARP inhibitors on the landscape of ovarian cancer.